How it works
Interlace Health does away with paper, clipboards, scanners – and even in-person appointments. Staff can quickly and easily assign a participant to a trial, automatically generate required actions for them to take on any device – at home or in the clinic. The participants can review the consent, explore additional educational information, flag any questions they have, and review them with a staff member later.
The participant feels fully engaged and educated about the trial they are joining and can then sign the form electronically when they are ready. Date & time stamps are automatically applied and the completed consent is archived electronically in the location you choose. The consents meet 21CFR Part 11 requirements, and the entire process, including re-consenting, is easier than ever before.
Improve patient experience and understanding
A recent study found that with a paper consent, research participants recalled about 58% of the material in informed consent documents, while 75% recalled information accurately when viewed in an eConsent format.
Interlace Health aims to improve communication and clinical trial efficiency by presenting information in a more easily digestible format with the ability to add links to additional resources. This ensures participants are truly informed when making a decision to participate in a trial.
Ensure automatic archival and compliance
Interlace Health’s Clinical Trial Consent solution integrates seamlessly with your EHR and clinical trial software.
Never again have missing required information on a form, or lost/misfiled forms. Ensure all required fields are completed, and that participants have checked or initialed that they understand what they’re signing.
Signed consents are instantly archived, immediately available, and never lost.
Support remote clinical trials
COVID-19 created an even greater urgency for clinical trials to go virtual. The FDA recommends using electronic consents when possible during the pandemic, and to ensure data integrity.
As many researchers have moved clinical trials to a virtual format, Interlace Health’s Clinical Trial Consent Solution safely provides information to participants remotely to continue trial enrollment during this unprecedented time of quarantines, travel restrictions, and restricted site visits.
Ready for a More Reliable Way to Consent Participants to Clinical Trials?
Informed participants = retained participants. Securing patient consent can be a barrier to clinical trial recruitment and retention. With 85% of studies failing to retain enough participants and an average dropout rate of 30% across trials, CROs and sponsors are searching for an efficient way to keep participants informed and engaged.
By increasing accessibility and enhancing participant understanding, it can improve clinical trial experiences for researchers, sponsors, and participants. Interlace Health’s Clinical Trial Consent Solution digitizes the process and eliminates paper consent, improving understanding and engagement, and ultimately accelerating and streamlining start-up times – leading to cost and time savings.
Why it’s better
Regulatory Compliance
Decreased risk and improved data quality
Participant Retention
Increase trial participation and outcome
Staff
Satisfaction
Enhanced workflows and happier staff